Factors associated with adverse COVID-19 outcomes in patients with psoriasis – insights from a global registry-based study
Background: The multi-morbid burden and use of systemic immunosuppressants in people with psoriasis may confer greater risk of adverse COVID-19 outcomes but data are limited. Objective: Characterize the course of COVID-19 in psoriasis and identify factors associated with hospitalization. Methods: Cl...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/14764
- Acceso en línea:
- https://doi.org/10.1016/j.jaci.2020.10.007
http://hdl.handle.net/20.500.12010/14764
- Palabra clave:
- COVID-19
Hospitalization
Psoriasis
Risk factors
Biologics
Mmunosuppressants
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)